跳至主要内容
临床试验/NCT05730400
NCT05730400已完成不适用

Histological Assessment of Deproteinized Bovine Bone Loaded by Bone Marrow Aspirate Versus Deproteinized Bovine Bone Alone for Guided Sinus Floor Elevation. (A Randomized Controlled Clinical Trial)

Cairo University1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2022年10月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
1
主要终点
Histological assessment

研究概览

简要总结

Aim : The aim of present study was to evaluate BMAC/bovine graft utilization in Sinus membrane augmentation on bone quality and quantity. Methodology: sixteen patients suffering from atrophic posterior maxilla with sinus pneumatization were randomly divided into two equal groups: study group: the sinus membrane was elevated with BMAC/bovine graft whereas the control group recieved bovine graft only for sinus floor augmentation.

All patients will be evaluated at 1 week, 4 months to measure bone height and bone core biopsy for histological assessment at 4 months during implant placement.

详细描述

Aim : The aim of present study was to evaluate BMAC/bovine graft utilization in Sinus membrane augmentation on bone height gain and quality of bone on histological assessment.

Methodology: sixteen patients suffering from atrophic posterior maxilla with sinus pneumatization were randomly divided into two equal groups: study group: the sinus membrane was elevated with bone marrow aspirate concentrate loaded on bovine graft whereas the control group recieved bovine graft only for sinus floor augmentation.

All patients will be evaluated at 1 week, 4 months by CBCT to measure bone height and bone core biopsy for histological assessment at 4 months during implant placement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with missing upper posterior teeth and atrophic posterior maxilla with a residual bone height ranging from 4 to 6 mm
  • Patients who has as deficient as 4 mm vertical bone height in posterior maxilla that need bone augmentation before delayed implant placement.
  • Highly motivated patients

排除标准

  • Patients suffering from any systemic disease or those under any medication that may interfere with normal bone healing.
  • Patients suffering from any sinus pathosis.
  • Patients with conditions that could potentially compromise BM quality, previous BMA, or acute illness.
  • Heavy smoker (> 20 cigarettes daily)

研究组 & 干预措施

BMAC/bovine graft

Active Comparator

Bone marrow aspirate concentrate loaded on bovine graft (Tutogen Medical GmbH, Neunkirchen am Brand, Germany, 1- 2mm particle size) utilization for sinus floor augmentation with residual alveolar bone height less than 5 mm, 1st arm

干预措施: BMAC loaded on bovine graft (Drug)

Bovine graft group

Active Comparator

bovine graft utilization for sinus floor augmentation with residual alveolar bone height less than 5 mm, 2nd arm

干预措施: Bovine graft only (Drug)

结局指标

主要结局

Histological assessment

时间窗: After 4 months of surgery

Histological assessment of core biopsy obtained at time of implant placement for percentage of new bone formation and residual graft

次要结局

  • Implant stability(After 4 months of surgery)
  • Bone gain(Preoperative, immediate and 4 months Postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Walaa Kadry

Lecturer of oral and Maxillofacial Surgery

Cairo University

研究点 (1)

Loading locations...

相似试验

Histological Assessment of BMAC Utilized in Sinus... | 临床试验